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Abstract
Background: Secretion of histotroph during the prolonged pre-implantation phase in mares is crucial to pregnancy
maintenance, manifested as increased embryonic loss in mares with age-related endometrial degeneration.
Glycogen content of uterine histotroph is higher during the progesterone-dominated phase of the estrous
cycle in mares, but regulatory mechanisms are not well understood.
Methods: mRNA expression of glycogen-metabolizing enzymes (HK1, HK2, GSK3B, GYS1, PEPCK, PKM, PYGM) in
endometrial samples were compared among mares in anestrus, estrus, and at Day 12 of diestrus and pregnancy.
In addition, hexokinase 2 (HK2) activity was assessed using a colorimetric assay.
Results: HK2 was the key regulator of glycogen accumulation during diestrus and pregnancy; hexokinase transcript
abundance and enzyme activity were significantly higher during diestrus and pregnancy than estrus and anestrus.
In addition, despite similar relative transcript abundance, hexokinase activity was significantly greater in the
pregnant versus diestrous endometrium. Therefore, we inferred there was regulation of hexokinase activity
through phosphorylation, in addition to its regulation at the transcriptional level during early pregnancy. Based
on immunohistochemistry, HK2 was localized primarily in luminal and glandular epithelial cells, with weaker
staining in stromal cells.
Conclusion: Among glycogen metabolizing enzymes identified, expression of HK2 was significantly greater
during the progesterone-dominated phase of the cycle.
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Background
There are two forms of nutrition for the developing equine
conceptus. Histotroph, also known as “uterine milk”, is
derived from the uterine glands and is the primary source
of nourishment prior to placental development [2]. The
importance of uterine secretions in early embryo develop-
ment has been emphasized as far back as the third century
B.C. by Aristoteles (cited in [11]). At approximately Day
40, implantation occurs and placentation commences,
marking the beginning of hemotrophic nutrition [1]. For
the remainder of gestation, both mechanisms of nutrition
are integral to fetal development [1]. Regardless, given the
prolonged pre-implantation period in the mare, adequate
histotroph is of particular importance to maintenance of
pregnancy. The majority of pregnancy loss in horses occurs
before Day 45 [21]; although the underlying reasons are
multifaceted, inadequate secretion of uterine histotroph
due to age-related endometrial degeneration likely contrib-
utes to increased early embryonic loss in older mares [15].
Glycogen, a storage form of glucose molecules, is one of
the endometrial secretions that comprise histotroph and
contribute to a successful pregnancy in a variety of spe-
cies, including mink and human [6, 19]. In the equine
endometrium, glycogen content is highest during diestrus,
lower during estrus, but almost absent during anestrus.
This cyclic variation in glycogen content is likely con-
trolled by variations in progesterone concentrations, char-
acteristic of various phases of the estrous cycle [9, 13]. In
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muscle, the process of glycogen synthesis, glycogenesis,
begins with conversion of glucose into glucose-6-
phosphate by hexokinase (primarily Hexokinase 1 and
2; HK1 and HK2). Glucose-6-phosphate is isomerized
to glucose-1-phosphate and is then converted into UDP-
glucose. Through glycogen synthase (GYS1), the glucose
of UDP-glucose is transferred to the non-reducing end of
a glycogen molecule [8]. The activity of GYS1 is regulated
by glycogen synthase kinase 3 beta (GSK3B); this enzyme
phosphorylates (and thereby inactivates) GYS1. In hu-
man endometrium, activity of GSK3B is regulated by
progesterone [23]. Glycogen degradation, glycogenoly-
sis, is catalyzed by glycogen phosphorylase (PYGM),
releasing glucose-1-phosphate, that can be converted
into glucose-6-phosphate, that can enter the glycolytic
pathway [6] or be hydrolyzed by glucose 6-phosphatase
(G6PC3) to form glucose.
Glycogen metabolism in human endometrium has
been studied extensively [19, 20, 23]. More recently,
uterine glycogen metabolism has been investigated in
mink [6, 22]. However, the presence and expression of
glycogen-metabolizing enzymes in the equine endomet-
rium have not been as well characterized. Objectives of
the present study were to describe gene and protein ex-
pression, as well as enzyme activity of glycogen metaboliz-
ing enzymes (GSK3B, GYS1, PYGM, HK1, HK2, and
PKM) in the endometrium during estrus, diestrus, preg-
nancy, and anestrus. To the best of our knowledge, no
study demonstrating distribution and activity of glycogen
metabolizing enzymes in equine endometrium during the
estrous cycle and early pregnancy has been published. We
hypothesized that expression of one or more glycogen me-
tabolizing enzyme in the equine endometrium is higher
during the progesterone-dominated phase of the estrous
cycle than estrus or anestrus.
Methods
Mares and tissue collection
All procedures were approved by the University of Calgary’s
Animal Care Committee (AC13-0068 and AC16-0002).
Prior to tissue collection, all mares underwent a breed-
ing soundness examination to assess reproductive
soundness. Only healthy mares less than 14 years of age
with no detectable abnormalities of the reproductive
tract were used. Endometrial tissue samples were col-
lected from estrous (n = 10), diestrous (n = 8), pregnant
(n = 8), and anestrous (n = 6) mares. Reproductive sta-
tus was determined via transrectal ultrasonography.
Estrous samples were obtained when a 35-mm follicle
and pronounced uterine edema was present. Diestrous
samples and samples from pregnant mares were ob-
tained 12 d post-ovulation, as described [17]. Anestrous
samples were collected in the winter when mares were
reproductively quiescent (confirmed through absence of
ovarian follicles > 10 mm). Endometrial biopsies were
collected transcervically using an alligator-type uterine
biopsy forceps. Following collection, tissue samples
were divided in half and were either preserved in 10%
formalin for 24 h and stored in 70% ethanol until em-
bedding in paraffin or snap-frozen in liquid nitrogen
and stored at −80°C until further processing. Presence
of age-related degenerative changes such as periglandu-
lar fibrosis was ruled out through light microscopic
examination. All samples were classified as either cat-
egory I or IIb according to the grading system intro-
duced by Kenney [15]. Tissue samples were collected
from 25 mares. Seven mares were used twice, and over-
all, 32 samples were collected.
Isolation of RNA
Total RNA was isolated from 75–100 mg of endometrial
tissue using TRIzol reagent (Thermo Fisher Scientific,
Ottowa, ON, Canada) according to the manufacturer’s in-
struction. The RNA (~50 μg) was adjusted to total volume
of 100 μL and precipitated using equal volumes of isopro-
panol and 1/10 volume of 3M sodium acetate pH 5.2.
Following centrifugation and washing of the resulting
RNA pellet using 75% ethanol, RNA was re-suspended in
water and RNA concentration was measured using a
NanoDrop (Thermo Fisher Scientific); samples with a
260/280 ratio close to 1.95, and a 260/230 ratio close to
2.0 were used for analysis.
Real-Time RT-PCR
RNA samples (1 μg) were treated with DNase I, Ampli-
fication Grade (Thermo Fisher Scientific) for 15 min at
room temperature, followed by heat inactivation with
EDTA for 10 min at 65°C, and then reverse transcribed
using a High-Capacity cDNA Reverse Transcription Kit
(Thermo Fisher Scientific).
For each endometrial sample, the mRNA expression
of seven transcripts, glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH), glycogen synthase kinase 3 beta
(GSK3B), glycogen synthase 1 (GYS1), glycogen phos-
phorylase (PYGM), hexokinase 1 (HK1), hexokinase 2
(HK2), and pyruvate kinase (PKM) were measured
using real-time PCR. Primers specific for selected tran-
scripts were designed using Primer-BLAST (National
Center for Biotechnology Information; Table 1). Real-
time PCR was performed using PowerUp SYBR Green
Master Mix (Thermo Fisher Scientific) with the following
conditions: one cycle of 10 min at 95°C; 40 cycles of 15 s
at 95°C, 1 min at 60°C; followed by generation of a melt
curve. Each reaction consisted of 5 μL of PowerUp SYBR
Green Master Mix, 3.5 μL of ddH2O, 0.5 μL of 10 μM
forward and reverse primers, and 0.5 μL of cDNA (total
volume of 10 μL per well). All PCR was performed in
duplicate. Negative controls consisted of water replacing
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cDNA and non-reverse transcribed RNA reactions. All re-
actions were automatically pipetted using the epMotion
Automated Pipetting System (Eppendorf, Mississauga,
ON, Canada). Primer efficiency was tested with 10-fold di-
lutions of pooled cDNA; it was confirmed that all primers
had a PCR efficiency from 90 to 100%. Primer specificity
was determined by melt-curve analysis yielding a single
melting temperature for each product and Sanger sequen-
cing to confirm product identity. The cycle number where
the fluorescent signal crossed the threshold (Cq) was re-
corded. Replicate Cq were averaged and Real-time RT-
PCR results were normalized to the housekeeping gene
GAPDH, by subtracting the Cq for GAPDH from the Cq
for each sample, to obtain delta Cq [18].
Immunohistochemistry
Tissues were embedded in paraffin, sections were cut at
5 μM and mounted onto positively charged slides.
Immunohistochemistry (IHC) was done with an auto-
mated IHC stainer, BOND-MAX (Leica, Richmond Hill,
ON, Canada), as described [16]. A polyclonal rabbit
anti-human hexokinase 2 antibody was used (Thermo
Fisher Scientific; PA5-29326). As negative control,
primary antibody was replaced with rabbit normal
serum. The recombinant fragment used to generate the
antibody (corresponding to amino acids 53 – 342 of
human hexokinase 2) is 93% homologous to equine
hexokinase 2, 73% homologous to equine hexokinase 1,
and 58% homologous to equine glucokinase. The anti-
body cross-reacted with equine HK2, based on Western
Blotting analysis (Thermo Fisher Scientific).
Hexokinase Activity
Equine endometrial HK activity was measured using a
Hexokinase Assay Kit (Abcam, Toronto, ON, Canada;
ab136957). For each endometrial sample, 10 mg tissue
was homogenized in 200 μL of ice cold Assay Buffer using
a Dounce homogenizer. Samples were centrifuged for 5
min at 4°C at 15,300 g and the resulting supernatant was
collected and stored on ice. For each tissue lysate, 1 μL of
sample and 49 μL of Assay Buffer were added to each
sample well, along with 50 μL of Colorimetric Reaction
Mix, followed by 50 μL of NADH standards along with 50
μL of Colorimetric Reaction Mix. A positive control was
prepared and 1 μL of positive control and 49 μL of Assay
Buffer were added to the positive control well, along
with 50 μL of Colorimetric Reaction Mix. Reaction
mixtures were incubated at room temperature for 60
min (protected from light). At the end of the incubation
period, optical density at 450 nm was determined using
a microplate reader (Spectra Max i3x, Molecular
Devices, Sunnyvale, CA, USA). In a preliminary trial,
measuring optical density at 450 nm in a kinetic mode
starting at 20 min of incubation, 60 min was confirmed
to be the ideal incubation period. Hexokinase activity
(expressed as nmol NADH generated) was calculated
according to the manufacturer’s instructions (Fig. 3).
Statistical analyses
Normality of data was confirmed with the D’agostino
and Pearson normality test. Delta Cq values for estrous,
diestrous, pregnant, and anestrous endometrium for
GSK3B, GYS1, PYGM, HK1, HK2, and PKM were com-
pared by one-way ANOVA. To determine differences in
hexokinase activity in endometrial lysates, nmol NADH
generated after 60 min of incubation were compared
using one-way ANOVA. Statistical analyses and graph-
ing of results were performed using GraphPad Prism 6




Relative transcript abundance of HK2 was highest (P < 0.01)
in samples collected during diestrus and pregnancy,
with no difference between samples collected during
anestrus versus estrus. Expression of GYS1 in the endo-
metrium was greater during pregnancy than anestrus
(P < 0.01). Samples from estrous mares had a higher
relative abundance of PYGM than samples collected from
diestrous mares (P < 0.5). For GSK3B, PYGM, HK1, and
PKM, there were no statistically significant differences in
Table 1 Forward and reverse primer sequences used for Real-Time RT-PCR
Transcript Forward primer sequence (5′ to 3′) Reverse primer sequence (5′ to 3′) Accession number
GAPDH TTGTCAAGCTCATTTCCTGGTATG GTTAGGGGGTCAAGTTGGGAC NM_001163856.1
GSK3B ACAGGCCACAAGAAGTCAGC GATGGCAACCAGTTCTCCTGA XM_005601948.2
GYS1 TGGAATCCCCACACTCCAGA AGGCAATAGGCCAGGTTTCC NM_001126125.2
PYGM GAGATCAACCAGCGCTTCCT GATCTCCGAGTGGATGCGAG NM_001145253.2
HK1 GCTGAGGAAGCAAACGAACG GTTCCTCCAAGATCCAGGGC XM_005602426.2
HK2 CTCAGAGCGGCTCAAGACAA GCACACCTCCTTGACGATGA NM_001081776.1
PKM AGAACTTGTGCGAGCCTCAA CTGTCTGGTGATTCCGGGTC NM_001143794.2
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH); Glycogen synthase kinase 3 beta (GSK3B); Glycogen synthase 1 (GYS1); Glycogen phosphorylase (PYGM);
Hexokinase 1 (HK1); Hexokinase 2 (HK2); Pyruvate kinase (PKM)
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transcript abundance amongst the reproductive statuses
examined. Note that results are displayed as 1 over delta
Cq to account for the inverse relationship of delta Cq and
relative mRNA abundance (Fig. 1).
Immunohistochemical localization of endometrial HK2
expression
Based on immunohistochemistry, HK2 was localized pri-
marily in luminal and glandular epithelial cells, with
Fig. 1 Relative transcript abundance of HK2, GSK3B, GYS1, HK1, PEPCK, PKM, and PYGM in equine endometrium during anestrus, estrus, Day 12 of
diestrus and Day 12 of pregnancy. Relative expression levels are depicted as 1/deltaCq to account for the inverse relationship of deltaCq and
relative transcript abundance. Means without a common superscript differed (P ≤ 0.05)
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weaker staining in stromal cells. Staining intensity of
luminal epithelial cells did not differ clearly between
estrous, diestrous and pregnant samples, whereas stain-
ing intensity of glandular epithelial cells differed between
the different stages examined. Staining intensity of glandu-
lar epithelial cells was strongest at Day 12 of pregnancy
with slightly less pronounced staining observed at Day 12
of diestrus. Estrous samples displayed moderate staining
intensity of glandular epithelial cells. No staining was
observed in the negative control. Images were taken at
200× magnification (Fig. 2).
Hexokinase Activity
HK activity (as measured by nmol NADH produced
during 60-min incubation) was higher in estrous than
anestrous endometrial lysates (P < 0.05). Likewise, dies-
trous (P < 0.001) and pregnant (P < 0.0001) samples had
higher hexokinase activity than anestrous samples.
Compared to estrous samples, both diestrous (P < 0.5)
and pregnant (P < 0.0001) samples were characterized
by higher hexokinase activity. Pregnant samples displayed
higher HK activity than diestrous samples (P < 0.001).
Results are displayed in Fig. 3 as nmol NADH produced
by 10 mg of endometrial lysate during 60-min incubation.
Discussion
In this study, expression of glycogen metabolizing
enzymes in equine endometrium during anestrus, estrus
and 12 days post ovulation in cycling and pregnant
mares was determined.. Herein, both mRNA and protein
expression of HK 2, as well as HK activity were signifi-
cantly greater during the progesterone-dominated phase
of the estrous cycle. Hexokinase activity was assessed
using a Hexokinase Assay Kit in which the conversion of
glucose to glucose-6-phosphate by hexokinase is mea-
sured. Based on immunohistochemistry, HK 2 expression
was most pronounced in glandular epithelial cells at Day
12 of pregnancy. Apart from HK 2, none of the other tran-
scripts investigated (i.e. GYS1, GSK3B, PYGM, HK1, or
PKM) had consistently higher expression during diestrus
and pregnancy compared to estrus and/or anestrus.
The significance of histotroph in establishment and
maintenance of pregnancy in the mare is well recog-
nized and is manifested in increased embryonic loss in
mares with endometrial fibrosis [15]. Various proteins
are known components of uterine secretions in the
mare, including uteroglobin [12], uterocalin [24], utero-
ferrin [25], and P19 [4]. Glycogen, through the release
of glucose, is an integral constituent of histotroph;
although accumulation of glycogen by the equine endo-
metrium under the influence of progesterone has been
described [9], expression of glycogen-metabolizing en-
zymes in the mare remains poorly defined. In human
endometrium, expression of GSK3B is suggested to be
regulated by progesterone, with higher expression of
phosphorylated GSK3B (inactive) in secretory versus
proliferative phases [23]. In mink, protein expression of
HK1 and PYGM was greatest during estrus and dia-
pause, whereas GYS protein expression was barely de-
tectable after estrus [6]. Furthermore, G6PC3 gene
expression was highest during diapause, suggesting that
progesterone is glycogenolytic in the mink endomet-
rium, as opposed to glycogenic in the human endomet-
rium [6]. In the current study, HK2 was significantly
upregulated during diestrus and pregnancy. Therefore,
we inferred that transcriptional regulation of HK2 was
involved in regulation of glycogen accumulation in the
equine endometrium. Even though relative mRNA
abundance of HK2 did not differ between diestrus and
pregnancy, HK2 activity was significantly higher in
samples obtained from pregnant versus non-pregnant
mares. Hexokinase activity can be regulated through
phosphorylation, with phosphorylation resulting in in-
creased activity [7]. Although phosphorylation status of
HK2 was not evaluated in the present study, based on
increased hexokinase activity in pregnant versus non-
pregnant diestrous samples, we inferred that HK2 likely
underwent differential phosphorylation during preg-
nancy. Glycogen Synthase 1 (GYS1), which catalyzes
addition of glucose monomers to the growing glycogen
molecule, had a trend for higher expression during the
progesterone-dominated phase of the estrous cycle,
Fig. 2 Immunohistochemical analysis of HK2 protein distribution in equine endometrium at estrus, and Day 12 of diestrus and pregnancy. Small
inserted panels show glands located in the stratum compactum. No staining was observed in the negative control (not shown)
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although it was only significant when comparing samples
obtained from anestrous mares with those obtained from
pregnant mares.
A substantial source of economic loss in the equine
breeding industry is attributed to pregnancy loss, which
ranges from 7 to 17%, with greatest susceptibility prior
to Day 60 [10]. More than 55% of pregnancy loss occurs
by Day 39 and 75% by Day 49, with the risk of preg-
nancy loss decreasing as pregnancy progresses [3]. In
early equine pregnancy, progesterone is essential for
embryo survival; therefore, the absence of progesterone
results in embryonic loss [10]. As mentioned previously,
glycogenesis is mediated by progesterone in the human
and equine endometrium [9, 14, 23]. Formation and
accumulation of glycogen contribute to histotrophic nu-
trition, the sole form of early embryonic nutrition prior
to establishment of haemotrophic nutrition. Therefore,
decreased progesterone concentrations and/or a reduced
response to progesterone could reduce the production
of endometrial glycogen, increasing the probability of
pregnancy loss. In one study [14] characterizing expres-
sion of secretory proteins, mucopolysaccharides, and
glycogen in endometrial biopsies of mares with varying
degrees of endometriosis, 32 of 48 biopsies had a cycle-
asynchronous decrease in staining intensity for glycogen,
implicating inadequate glycogen accumulation as a cause
of increased embryonic loss in mares with degenerative
endometrial changes. Given the frequent use of proges-
terone supplementation during early pregnancy in the
mare [5], studies are warranted to determine whether
exogenous progesterone during diestrus can further in-
crease hexokinase activity, resulting in increased glycogen
content of the endometrium.
Conclusions
In this study, HK2 was the predominant enzyme control-
ling glycogen accumulation in the equine endometrium
during diestrus and pregnancy. Follow-up studies should
focus on comparing expression levels of HK2 between
endometrial samples obtained from diestrous mares with
varying Kenny and Doig scores (e.g. Grade 1 compared to
Grades IIb or III) to determine whether HK2 expression is
impaired with endometrial degeneration, and whether
exogenous progesterone supplementation can increase
hexokinase activity, and consequently, endometrial glyco-
gen content.
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